Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273) Read more
Xencor and Atreca Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies Read more
Concert Receives FDA Breakthrough Therapy Designation for CTP-543 for the Treatment of Alopecia Areata Read more
LYNPARZA (olaparib) Approved in the EU for Germline BRCA-mutated Metastatic Pancreatic Cancer Read more
Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19 Read more
Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China Read more
EIB and EC provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing Read more
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine Read more